|
2020
|
Invention
|
Heterocyclic derivatives and use thereof. Provided are certain URAT1 inhibitors, pharmaceutical c... |
|
|
Invention
|
Substituted pyrrolo [2, 3-b] pyridine and pyrazolo [3,4-b] pyridine derivatives as protein kinase... |
|
|
Invention
|
Substituted pyrrolo [2, 3-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinas... |
|
2019
|
Invention
|
Naphthyridinone and pyridopyrimidinone compounds useful as kinases inhibitors. Provided are certa... |
|
|
Invention
|
Substituted imidazo [1, 2-a] pyridine and [1, 2, 4] triazolo [1, 5-a] pyridine compounds as ret k... |
|
|
Invention
|
Substituted [1, 2, 4] triazolo [1, 5-a] pyridine compounds as ret kinase inhibitors. Provided are... |
|
|
Invention
|
Macrocyclic compounds as trk kinases inhibitors. Provided are certain TRK inhibitors, pharmaceuti... |
|
|
Invention
|
Deuterated compounds as rock inhibitors. Provided are compounds of Formular (I), or pharmaceutica... |
|
|
Invention
|
Substituted (2-azabicyclo [3.1.0] hexan-2-yl) pyrazolo [1, 5-a] pyrimidine and imidazo [1, 2-b] p... |
|
2018
|
Invention
|
Apoptosis-inducing agents. Provided are certain Bcl-2 inhibitors, pharmaceutical compositions the... |
|
|
Invention
|
Compounds as bcl-2-selective apoptosis-inducing agents. Provided are certain Bcl-2 inhibitors, ph... |
|
2017
|
Invention
|
Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of ind... |
|
|
Invention
|
Substituted pyrrolo [2, 3-d] pyridazin-4-ones and pyrazolo [3, 4-d] pyridazin-4-ones as protein k... |
|
|
Invention
|
Certain protein kinase inhibitors. Provided are certain CDK4/6 inhibitors, pharmaceutical composi... |
|
|
Invention
|
Phosphorus containing compounds as protein kinase inhibitors. Provided are certain ALK inhibitors... |
|
|
Invention
|
Fused pyridine compounds, compositions and methods of use. Provided are certain URAT1 inhibitors,... |
|
2016
|
Invention
|
Indolizine derivatives, composition and methods of use. Provided are certain URAT1 inhibitors, ph... |
|
|
Invention
|
Certain protein kinase inhibitor. Provided are certain CDK4/6 inhibitors, pharmaceutical composit... |
|
2015
|
Invention
|
Certain protein kinase inhibitors. Provided are certain PI3K inhibitors, pharmaceutical compositi... |
|
|
Invention
|
Certain protein kinase inhibitors. Disclosed herein are protein kinase inhibitors, more particula... |
|
|
Invention
|
Certain protein kinase inhibitors. Provided are certain EGFR mutant selective inhibitors, pharmac... |
|
|
Invention
|
Certain protein kinase inhibitors. Provided are compound of formula (I) as certain CDK4/6 inhibit... |
|
|
Invention
|
Crystal form α of compound a monobenzoate and preparation method thereof and pharmaceutical compo... |
|
2014
|
Invention
|
Quinazoline derivatives, compositions thereof, and use as pharmaceuticals. Disclosed herein are p... |
|
|
Invention
|
Certain protein kinase inhibitors. Disclosed herein are protein kinase inhibitors,more particular... |
|
2013
|
Invention
|
Certain dipeptidyl peptidase inhibitors.
Provided are certain dipeptidyl peptidase inhibitors, p... |
|
|
Invention
|
Certain dipeptidyl peptidase inhibitors. Provided are certain dipeptidyl peptidase inhibitors, ph... |
|
|
Invention
|
Alk kinase inhibitors. Disclosed herein are ALK kinase inhibitors, pharmaceutical compositions th... |
|
2011
|
Invention
|
Certain dipeptidyl peptidase inhibitors. Provided are compounds represented by formula (I), their... |
|
2010
|
Invention
|
2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptid... |
|
|
Invention
|
Certain dipeptidyl peptidase inhibitors. Disclosed are compounds represented by formula (I) and t... |
|
|
Invention
|
3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhib... |
